CAPTRUST Financial Advisors
AGIO icon

CAPTRUST Financial Advisors’s Agios Pharmaceuticals AGIO Stock Holding History

CAPTRUST Financial Advisors’s Portfolio AGIO Stock Details AGIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$421K Buy
+11,351
New +$344K ﹤0.01% 2300
2022
Q3 		– Sell
-196
Closed -$4K – 2101
2022
Q2 		$4K Buy
196
+30
+18% +$678 ﹤0.01% 4156
2022
Q1 		$5K Buy
166
+158
+1,975% +$4.83K ﹤0.01% 4130
2021
Q4 		$0 Sell
8
-24
-75% -$966 ﹤0.01% 4751
2021
Q3 		$1K Sell
32
-571
-95% -$27.6K ﹤0.01% 4393
2021
Q2 		$33K Sell
603
-1,125
-65% -$62.9K ﹤0.01% 2767
2021
Q1 		$89K Buy
1,728
+347
+25% +$17.2K ﹤0.01% 2039
2020
Q4 		$60K Sell
1,381
-20
-1% -$791 ﹤0.01% 1740
2020
Q3 		$49K Buy
1,401
+57
+4% +$2.5K ﹤0.01% 1633
2020
Q2 		$75K Buy
+1,344
New +$62.2K ﹤0.01% 1460

Other funds holding AGIO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
LCM
Lynx1 Capital Management San Juan, Puerto Rico $866M AUM 231.68% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $66.6B AUM

CAPTRUST Financial Advisors's AGIO Position: Q2 2026 in Review

CAPTRUST Financial Advisors opened a new position in Agios Pharmaceuticals (AGIO) in Q2 2026: 11,351 shares worth $421K. The stake represents ﹤0.01% of the portfolio and ranks #2300 among its holdings. This is a return to the name: CAPTRUST Financial Advisors previously reported a position in AGIO as recently as Q2 2022.

CAPTRUST Financial Advisors first reported a position in AGIO in Q2 2020 and has held it in 10 quarters since. 239 funds tracked by Wall St. Rank hold AGIO as of Q2 2026.

  • CAPTRUST Financial Advisors held 11,351 shares of Agios Pharmaceuticals worth $421K as of Q2 2026.
  • Agios Pharmaceuticals was a new CAPTRUST Financial Advisors position in Q2 2026.
  • Agios Pharmaceuticals made up ﹤0.01% of CAPTRUST Financial Advisors's portfolio in Q2 2026, its #2300 holding.
  • CAPTRUST Financial Advisors first reported a position in Agios Pharmaceuticals in Q2 2020 and has held it in 10 quarters since.
  • 239 funds tracked by Wall St. Rank held Agios Pharmaceuticals as of Q2 2026.

Based on CAPTRUST Financial Advisors's 13F filing for Q2 2026, filed 13 Aug 2026.